blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
FAQ - Register Alert
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP1771466

EP1771466 - CELL CYCLE PHASE MARKERS [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  01.04.2011
Database last updated on 03.09.2024
Most recent event   Tooltip11.10.2013Lapse of the patent in a contracting state
New state(s): ES		published on 13.11.2013  [2013/46]
Applicant(s)For all designated states
GE Healthcare Limited
Amersham Place
Little Chalfont, Buckinghamshire HP7 9NA / GB
For all designated states
Vanderbilt University
305 Kirkland Hall
2201 West End Avenue
Nashville, TN 37240 / US
[N/P]
Former [2007/15]For all designated states
GE Healthcare UK Limited
Amersham Place Little Chalfont
Buckinghamshire HP7 9NA / GB
For all designated states
Vanderbilt University
2201 West End Avenue
Nashville, TN 37235 / US
Inventor(s)01 / HANCOCK, Suzanne, The Maynard Centre
Forest Farm Estate
Whitchuch, Cardiff CF14 7YT / GB
02 / STUBBS, Simon, The Maynard Centre
Forest Farm Estate
Whitchurch, Cardiff CF14 7YT / GB
03 / THOMAS, Nicholas, The Maynard Centre
Forest Farm Estate
Whitchurch, Cardiff CF14 7YT / GB
04 / FANNING, Ellen, Department of Biological Sciences
Vanderbilt University VU Station B 351634
Nashville, TN 37235 / US
05 / GU, Jinming
44 Binney Street, Mayer 457 Dana-Farber Cancer I.
Boston, MA 02115 / US
 [2007/15]
Representative(s)Bryan, Ian Bennett, et al
GE Healthcare Limited
Amersham Place
Little Chalfont, Bucks. HP7 9NA / GB
[N/P]
Former [2007/15]Bryan, Ian Bennett, et al
GE Healthcare Limited Amersham Place
GB-Little Chalfont, Bucks. HP7 9NA / GB
Application number, filing date05766537.422.07.2005
[2007/15]
WO2005GB02884
Priority number, dateUS20040590814P23.07.2004         Original published format: US 590814 P
US20050645915P21.01.2005         Original published format: US 645915 P
US20050645968P21.01.2005         Original published format: US 645968 P
[2007/15]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2006008542
Date:26.01.2006
Language:EN
[2006/04]
Type: A1 Application with search report 
No.:EP1771466
Date:11.04.2007
Language:EN
The application published by WIPO in one of the EPO official languages on 26.01.2006 takes the place of the publication of the European patent application.
[2007/15]
Type: B1 Patent specification 
No.:EP1771466
Date:26.05.2010
Language:EN
[2010/21]
Search report(s)International search report - published on:EP26.01.2006
ClassificationIPC:C07K14/47, C12N15/62, G01N33/50
[2007/15]
CPC:
C07K14/4738 (EP,US); C12N15/1034 (EP,US); C07K2319/60 (EP,US)
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   NL,   PL,   PT,   RO,   SE,   SI,   SK,   TR [2007/15]
Extension statesALNot yet paid
BANot yet paid
HRNot yet paid
MKNot yet paid
YUNot yet paid
TitleGerman:ZELLCYCLUSPHASENMARKER[2007/15]
English:CELL CYCLE PHASE MARKERS[2007/15]
French:MARQUEURS DE PHASES DU CYCLE CELLULAIRE[2007/15]
Entry into regional phase24.01.2007National basic fee paid 
24.01.2007Designation fee(s) paid 
24.01.2007Examination fee paid 
Examination procedure23.05.2006Request for preliminary examination filed
International Preliminary Examining Authority: EP
24.01.2007Examination requested  [2007/15]
21.05.2007Despatch of a communication from the examining division (Time limit: M06)
07.01.2008Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time
06.03.2008Reply to a communication from the examining division
23.12.2009Communication of intention to grant the patent
26.03.2010Fee for grant paid
26.03.2010Fee for publishing/printing paid
Opposition(s)01.03.2011No opposition filed within time limit [2011/18]
Request for further processing for:The application is deemed to be withdrawn due to failure to reply to the examination report
06.03.2008Request for further processing filed
06.03.2008Full payment received (date of receipt of payment)
Request granted
20.03.2008Decision despatched
Fees paidRenewal fee
27.07.2007Renewal fee patent year 03
25.07.2008Renewal fee patent year 04
28.07.2009Renewal fee patent year 05
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipAT26.05.2010
BE26.05.2010
CY26.05.2010
CZ26.05.2010
DK26.05.2010
EE26.05.2010
FI26.05.2010
IT26.05.2010
LT26.05.2010
LV26.05.2010
NL26.05.2010
PL26.05.2010
RO26.05.2010
SE26.05.2010
SI26.05.2010
SK26.05.2010
TR26.05.2010
IE22.07.2010
LU22.07.2010
CH31.07.2010
LI31.07.2010
MC31.07.2010
BG26.08.2010
GR27.08.2010
ES06.09.2010
IS26.09.2010
PT27.09.2010
HU27.11.2010
[2013/46]
Former [2013/42]AT26.05.2010
BE26.05.2010
CY26.05.2010
CZ26.05.2010
DK26.05.2010
EE26.05.2010
FI26.05.2010
IT26.05.2010
LT26.05.2010
LV26.05.2010
NL26.05.2010
PL26.05.2010
RO26.05.2010
SE26.05.2010
SI26.05.2010
SK26.05.2010
TR26.05.2010
IE22.07.2010
LU22.07.2010
CH31.07.2010
LI31.07.2010
MC31.07.2010
BG26.08.2010
GR27.08.2010
IS26.09.2010
PT27.09.2010
HU27.11.2010
Former [2012/47]AT26.05.2010
BE26.05.2010
BG26.05.2010
CY26.05.2010
CZ26.05.2010
DK26.05.2010
EE26.05.2010
FI26.05.2010
IT26.05.2010
LT26.05.2010
LV26.05.2010
NL26.05.2010
PL26.05.2010
RO26.05.2010
SE26.05.2010
SI26.05.2010
SK26.05.2010
TR26.05.2010
IE22.07.2010
LU22.07.2010
CH31.07.2010
LI31.07.2010
MC31.07.2010
GR27.08.2010
IS26.09.2010
PT27.09.2010
HU27.11.2010
Former [2012/44]AT26.05.2010
BE26.05.2010
BG26.05.2010
CY26.05.2010
CZ26.05.2010
DK26.05.2010
EE26.05.2010
FI26.05.2010
IT26.05.2010
LT26.05.2010
LV26.05.2010
NL26.05.2010
PL26.05.2010
RO26.05.2010
SE26.05.2010
SI26.05.2010
SK26.05.2010
IE22.07.2010
LU22.07.2010
CH31.07.2010
LI31.07.2010
MC31.07.2010
GR27.08.2010
IS26.09.2010
PT27.09.2010
HU27.11.2010
Former [2012/42]AT26.05.2010
BE26.05.2010
BG26.05.2010
CY26.05.2010
CZ26.05.2010
DK26.05.2010
EE26.05.2010
FI26.05.2010
IT26.05.2010
LT26.05.2010
LV26.05.2010
NL26.05.2010
PL26.05.2010
RO26.05.2010
SE26.05.2010
SI26.05.2010
SK26.05.2010
IE22.07.2010
CH31.07.2010
LI31.07.2010
MC31.07.2010
GR27.08.2010
IS26.09.2010
PT27.09.2010
HU27.11.2010
Former [2012/41]AT26.05.2010
BE26.05.2010
BG26.05.2010
CY26.05.2010
CZ26.05.2010
DK26.05.2010
EE26.05.2010
FI26.05.2010
IT26.05.2010
LT26.05.2010
LV26.05.2010
NL26.05.2010
PL26.05.2010
RO26.05.2010
SE26.05.2010
SI26.05.2010
SK26.05.2010
IE22.07.2010
CH31.07.2010
LI31.07.2010
MC31.07.2010
GR27.08.2010
IS26.09.2010
PT27.09.2010
Former [2011/36]AT26.05.2010
BE26.05.2010
CY26.05.2010
CZ26.05.2010
DK26.05.2010
EE26.05.2010
FI26.05.2010
IT26.05.2010
LT26.05.2010
LV26.05.2010
NL26.05.2010
PL26.05.2010
RO26.05.2010
SE26.05.2010
SI26.05.2010
SK26.05.2010
IE22.07.2010
CH31.07.2010
LI31.07.2010
MC31.07.2010
GR27.08.2010
IS26.09.2010
PT27.09.2010
Former [2011/20]AT26.05.2010
BE26.05.2010
CY26.05.2010
CZ26.05.2010
DK26.05.2010
EE26.05.2010
FI26.05.2010
IT26.05.2010
LT26.05.2010
LV26.05.2010
NL26.05.2010
PL26.05.2010
RO26.05.2010
SE26.05.2010
SI26.05.2010
SK26.05.2010
CH31.07.2010
LI31.07.2010
MC31.07.2010
GR27.08.2010
IS26.09.2010
PT27.09.2010
Former [2011/16]AT26.05.2010
BE26.05.2010
CY26.05.2010
CZ26.05.2010
DK26.05.2010
EE26.05.2010
FI26.05.2010
IT26.05.2010
LT26.05.2010
LV26.05.2010
NL26.05.2010
PL26.05.2010
RO26.05.2010
SE26.05.2010
SI26.05.2010
SK26.05.2010
MC31.07.2010
GR27.08.2010
IS26.09.2010
PT27.09.2010
Former [2011/12]AT26.05.2010
CY26.05.2010
CZ26.05.2010
DK26.05.2010
EE26.05.2010
FI26.05.2010
LT26.05.2010
LV26.05.2010
NL26.05.2010
PL26.05.2010
RO26.05.2010
SE26.05.2010
SI26.05.2010
SK26.05.2010
MC31.07.2010
GR27.08.2010
IS26.09.2010
PT27.09.2010
Former [2011/08]AT26.05.2010
CY26.05.2010
DK26.05.2010
EE26.05.2010
FI26.05.2010
LT26.05.2010
LV26.05.2010
NL26.05.2010
PL26.05.2010
SE26.05.2010
SI26.05.2010
GR27.08.2010
IS26.09.2010
PT27.09.2010
Former [2011/07]AT26.05.2010
CY26.05.2010
DK26.05.2010
FI26.05.2010
LT26.05.2010
LV26.05.2010
NL26.05.2010
PL26.05.2010
SE26.05.2010
SI26.05.2010
GR27.08.2010
IS26.09.2010
Former [2011/05]AT26.05.2010
CY26.05.2010
FI26.05.2010
LT26.05.2010
LV26.05.2010
PL26.05.2010
SE26.05.2010
SI26.05.2010
GR27.08.2010
IS26.09.2010
Former [2011/04]AT26.05.2010
FI26.05.2010
LT26.05.2010
LV26.05.2010
PL26.05.2010
SE26.05.2010
SI26.05.2010
GR27.08.2010
IS26.09.2010
Former [2011/01]AT26.05.2010
FI26.05.2010
LT26.05.2010
LV26.05.2010
SE26.05.2010
SI26.05.2010
GR27.08.2010
IS26.09.2010
Cited inInternational search[XD]WO03031612  (AMERSHAM BIOSCIENCES UK LTD [GB], et al) [XD] 1-40 * see whole doc. esp. claims *;
 [XD]  - GU J. ET AL.,, "cell cycle-dependent regulation of a human dna helicase that localizes in dna damage foci", MOLECULAR BIOLOGY OF THE CELL, (20040514), vol. 15, pages 3320 - 3332, XP002352929 [XD] 1-40 * the whole document *

DOI:   http://dx.doi.org/10.1091/mbc.E04-03-0227
 [AD]  - TANEJA P. ET AL.,, "a dominant-negative mutant of human DNA helicase b blocks the onset of chromosomal dna replication", J. BIOL. CHEMISTRY, (20021025), vol. 277, no. 43, pages 40853 - 40861, XP002352930 [AD] * the whole document *

DOI:   http://dx.doi.org/10.1074/jbc.M208067200
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.